Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 7 (July)

1. Update on the drug treatment of hypertension in patients with cardiovascular disease.
   Am J Med, 118(7): 695-705. [Abstract] [Full-text]
2. Women with diabetes have poorer control of blood pressure than men.
   J Womens Health (Larchmt), 14(5): 418-23. [Abstract] [Full-text]
3. Pre-existing hypertension and the impact of stroke on cognitive function.
   Ann Neurol, 58(1): 68-74. [Abstract] [Full-text]
4. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
   Eur J Pharmacol, 516(3): 253-9. [Abstract] [Full-text]
5. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
   Exp Physiol, 90(4): 449-55. [Abstract] [Full-text]
6. Deletion polymorphism in the gene for angiotensin-converting enzyme is associated with essential hypertension in men born during the Pacific War.
   Mech Ageing Dev, 126(8): 899-905. [Abstract] [Full-text]
7. Depolarization pattern of ventricular epicardium in two-kidney one-clip hypertensive rats.
   Exp Physiol, 90(4): 621-6. [Abstract] [Full-text]
8. Global link between heart rate and blood pressure oscillations at rest and during mental arousal in normotensive and hypertensive subjects.
   Auton Neurosci, 120(1): 80-7. [Abstract] [Full-text]
9. Value of routine funduscopy in patients with hypertension: systematic review.
   BMJ, 331(7508): 73. [Abstract] [Full-text]
10. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.
    J Clin Invest, 115(7): 1942-52. [Abstract] [Full-text]
11. Chromogranin A: a surprising link between granule biogenesis and hypertension.
    J Clin Invest, 115(7): 1711-3. [Abstract] [Full-text]
12. A chronic dysfunctional stress response can cause stroke by stimulating platelet activation, migraine, and hypertension.
    Med Hypotheses, 65(3): 542-5. [Abstract] [Full-text]
13. Enhanced expression of EGF receptor in a model of salt-sensitive hypertension.
    Am J Physiol Renal Physiol, 289(2): F314-21. [Abstract] [Full-text]
14. The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension.
    Am J Physiol Renal Physiol, 289(2): F393-400. [Abstract] [Full-text]
15. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study.
    Arch Intern Med, 165(13): 1541-6. [Abstract] [Full-text]
16. Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.
    Fundam Clin Pharmacol, 19(4): 429-37. [Abstract] [Full-text]
17. Developmental determinants of blood pressure in adults.
    Annu Rev Nutr, 25: 407-34. [Abstract] [Full-text]
18. Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers.
    Kidney Int, 68(2): 779-87. [Abstract] [Full-text]
19. Prolonged attenuation of cold-induced hypertension by adenoviral delivery of renin antisense.
    Kidney Int, 68(2): 680-7. [Abstract] [Full-text]
20. Aberrant ETB receptor regulation of AT receptors in immortalized renal proximal tubule cells of spontaneously hypertensive rats.
    Kidney Int, 68(2): 623-31. [Abstract] [Full-text]
21. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production.
    Am J Physiol Heart Circ Physiol, 289(2): H813-22. [Abstract] [Full-text]
22. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
    Am J Physiol Heart Circ Physiol, 289(2): H777-84. [Abstract] [Full-text]
23. Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study.
    Am J Obstet Gynecol, 193(1): 178-84. [Abstract] [Full-text]
24. Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome.
    Microcirculation, 12(5): 383-92. [Abstract] [Full-text]
25. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension.
    Am J Cardiol, 96(2): 252-6. [Abstract] [Full-text]
26. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension.
    Am J Cardiol, 96(2): 243-51. [Abstract] [Full-text]
27. Relationships between membrane lipids and ion transport in red blood cells of Dahl rats.
    Life Sci, 77(13): 1452-64. [Abstract] [Full-text]
28. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence.
    Br J Ophthalmol, 89(8): 960-3. [Abstract] [Full-text]
29. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus.
    J Pediatr, 147(1): 67-73. [Abstract] [Full-text]
30. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia.
    Acta Obstet Gynecol Scand, 84(8): 788-93. [Abstract] [Full-text]
31. Impairment of cardiac function in hypertensive patients with Type 2 diabetes: a LIFE study.
    Diabet Med, 22(8): 1005-11. [Abstract] [Full-text]
32. Control of hypertension in patients at high risk of cardiovascular disease.
    QJM, 98(8): 581-8. [Abstract] [Full-text]
33. Paraventricular nucleus, stress response, and cardiovascular disease.
    Clin Auton Res, 15(4): 254-63. [Abstract] [Full-text]
34. The age-dependent relation of blood pressure to cognitive function and dementia.
    Lancet Neurol, 4(8): 487-99. [Abstract] [Full-text]
35. Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats.
    Blood Press, 14(3): 184-92. [Abstract] [Full-text]
36. Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy.
    Blood Press, 14(3): 177-83. [Abstract] [Full-text]
37. Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUM-HTA study.
    Blood Press, 14(3): 151-8. [Abstract] [Full-text]
38. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment--a national study in Sweden.
    Blood Press, 14(3): 144-50. [Abstract] [Full-text]
39. Who's really hypertensive?--Quality control issues in the assessment of blood pressure for randomized trials.
    Blood Press, 14(3): 133-8. [Abstract] [Full-text]
40. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
    Blood Press, 14(2): 120-5. [Abstract] [Full-text]
41. Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat.
    Blood Press, 14(2): 114-9. [Abstract] [Full-text]
42. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Blood Press, 14(2): 107-13. [Abstract] [Full-text]
43. The association between maternal obesity, glucose intolerance and hypertensive disorders of pregnancy in nondiabetic pregnant women.
    Hypertens Pregnancy, 24(2): 125-36. [Abstract] [Full-text]
44. The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy.
    Hypertens Pregnancy, 24(2): 117-23. [Abstract] [Full-text]
45. Leptin, fetal nutrition, and long-term outcomes for adult hypertension.
    Endothelium, 12(1): 73-9. [Abstract] [Full-text]
46. Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin.
    Pharmacology, 74(4): 209-15. [Abstract] [Full-text]
47. Voluntary exercise training enhances glucose transport but not insulin signaling capacity in muscle of hypertensive TG(mREN2)27 rats.
    J Appl Physiol, 99(1): 357-62. [Abstract] [Full-text]
48. A generalized physiological hyperreactivity to acute stressors in hypertensives.
    Biol Psychol, 70(1): 44-51. [Abstract] [Full-text]
49. Hypertension in adults across the age spectrum: current outcomes and control in the community.
    JAMA, 294(4): 466-72. [Abstract] [Full-text]
50. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Can J Physiol Pharmacol, 83(6): 467-75. [Abstract] [Full-text]
51. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
    Can J Physiol Pharmacol, 83(6): 453-8. [Abstract] [Full-text]
52. The egogram is a potent, independent risk factor for hypertension in pregnancy.
    Semin Thromb Hemost, 31(3): 302-6. [Abstract] [Full-text]
53. Recurrence and extension of lobar hemorrhage related to cerebral amyloid angiopathy: multivariate analysis of clinical risk factors.
    Surg Neurol, 64(2): 160-4; discussion 164. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.